简体中文
客服电话(86) - 21 - 5081 2869,投诉邮箱地址:compliance@huixiaolaw.cn

们致力于为您本土及全球业务的成功提供解决方案!

We Are Committed to Providing Solutions for Your Local and Global Businesses! 

     


正直  专业  创新  负责  灵活  多元  变化

                   Professional Integrity                 

                                     Client Focus

                                               Innovative Thinking 

                                                                Quality Control   

                                                                            Diversified Flexibility  

                                                                                                     Ensuring Change    

                                                                                                                                    


     

慧晓新闻资讯

新闻资讯

News & Information


2025年3月:慧晓律所主任谢晓云在安拓平台为13家跨国医药和医疗器械公司提供《赞助合同的核心问题及主要条款设计》培训March 2025: Ellen Xie Managing Director of Hui Xiao Law Group Provided Training on Key Issues of Sponsorship Contract and Design Via EverPro to 13 Multinational Pharma & Medical Device Corporation
来源:慧晓HUI XIAO | 作者:慧晓HUI XIAO | 发布时间: 2025-03-15 | 34 次浏览 | 分享到:

202537日下午,上海慧晓律师事务所主任和律师、中国和美国执业律师谢晓云借助安拓平台圆满完成新年第一讲《赞助合同的核心问题及主要条款设计》,同时结合自身职业经验和剑桥大学及新加坡调解中心学习从各不同角度分享公司法务合规人员职业责任、技能和前景,参加的跨国医药企业包括第一三共、赛诺菲、威高、益普生、康哲、豪森、勃林格、康希诺、白洋医药、贝朗、扬子江、青岛百洋、康哲。

In the afternoon of 7 Mar 2025, Ms. Ellen Xie, Managing Director of Shanghai Hui Xiao Law Group and lawyer admitted in China and the United States, provided via Ever Pro platform a training on the Key Issues of Sponsorship Contract and Clauses Design to nearly 20 multinational pharmaceuticals and medical devices corporations and also shared her views on professional duties, skills and career prospects of an in-house corporate counsel and compliance officer from different dimensions and by combining her professional experience and knowledge and what she learned through her study at the University of Cambridge and Singapore Mediation Centre and won good feedbacks from attendees.  Attendees included Daiichi Sankyo, LaNova, Leo, Sanofi, WEGO, Ipsen, CMS, HANSOH, Boehringer-Ingelheim, Cansinotech, Baheal Pharma, BRAUN, Yangtze River, Qingdao Baiyang and China Medical System.